Update: 07.03.2023
Last week: 8 week 2023 (20.02.2023 - 26.02.2023)
Last full month: January 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 101 174 | -5.6% | 2.7% | 0 | 27 203 998 | -6.6% | 3.3% | 0 | -5.4% |
| MoM | 520 912 | -40.9% | 2.8% | -0.3 | 140 500 936 | -33.7% | 3.5% | 0.1 | -34.9% |
| YTD | 881 010 | -69.1% | 2.8% | -3.2 | 238 939 600 | -56.1% | 3.4% | -2.4 | -33.0% |
| MAT | 7 872 806 | -46.6% | 4.1% | -2.4 | 1 715 033 572 | -34.1% | 4.2% | -1.8 | -15.4% |
| DEXALGIN | |||||||||
| WoW | 14 392 | -7.3% | 0.3% | 0 | 7 957 033 | -7.1% | 1.1% | 0 | -5.8% |
| MoM | 86 116 | -0.8% | 0.4% | 0.1 | 45 595 997 | 7.9% | 1.4% | 0.3 | -18.7% |
| YTD | 138 589 | -60.1% | 0.4% | -0.4 | 74 553 635 | -45.0% | 1.3% | -0.8 | -20.6% |
| MAT | 1 377 010 | -28.0% | 0.5% | -0.2 | 625 815 302 | -14.6% | 1.6% | -0.4 | -6.8% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 47 914 | -9.4% | 38.7% | 1 | 30 161 157 | -9.9% | 48.2% | 1.2 | -11.9% |
| MoM | 227 468 | -5.8% | 39.3% | -1.6 | 147 485 006 | 4.4% | 50.3% | 1.4 | -1.9% |
| YTD | 406 440 | -53.3% | 38.9% | -21.5 | 261 128 940 | -36.9% | 49.3% | -17.6 | -27.4% |
| MAT | 3 821 024 | -28.0% | 49.8% | -14.8 | 2 056 077 736 | -16.9% | 56.1% | -13.5 | -6.6% |
| ESPUMISAN BABY | |||||||||
| WoW | 19 382 | -6.6% | 29.0% | 0.2 | 15 128 302 | -7.0% | 46.0% | -0.1 | -7.4% |
| MoM | 89 583 | -11.4% | 29.6% | -1.8 | 69 808 712 | -2.9% | 46.7% | -0.1 | -5.9% |
| YTD | 161 171 | -38.6% | 29.5% | -9.4 | 126 007 911 | -17.8% | 46.7% | -6.5 | -19.1% |
| MAT | 1 324 984 | -19.0% | 35.5% | -5.3 | 878 367 641 | -8.5% | 49.3% | -6 | -7.1% |
| FASTUM | |||||||||
| WoW | 12 656 | -8.7% | 0.8% | 0 | 7 691 928 | -8.6% | 2.2% | 0 | -7.8% |
| MoM | 68 305 | 1.6% | 0.9% | 0.1 | 41 973 451 | 9.7% | 2.6% | 0.4 | -9.0% |
| YTD | 115 213 | -47.6% | 0.9% | -0.5 | 70 490 937 | -31.5% | 2.4% | -0.7 | -15.8% |
| MAT | 936 016 | -31.4% | 1.0% | -0.4 | 513 982 294 | -19.1% | 2.4% | -0.7 | -3.1% |
| IODOMARIN | |||||||||
| WoW | 61 078 | -11.9% | 22.2% | -0.2 | 11 503 000 | -11.6% | 9.0% | 0 | -11.3% |
| MoM | 257 852 | -11.8% | 20.9% | -1 | 47 712 069 | -11.1% | 8.0% | -0.6 | -7.4% |
| YTD | 491 594 | -17.4% | 21.6% | -0.5 | 91 571 730 | -17.3% | 8.5% | -1.3 | -15.4% |
| MAT | 3 189 876 | -4.1% | 20.4% | -0.8 | 620 823 811 | 0.0% | 8.9% | -0.7 | -0.4% |
| LIOTON | |||||||||
| WoW | 14 458 | -18.9% | 1.7% | -0.2 | 17 861 918 | -21.1% | 4.3% | -0.6 | -10.2% |
| MoM | 59 882 | -11.1% | 1.6% | 0 | 74 104 261 | -7.1% | 4.1% | -0.1 | -8.3% |
| YTD | 118 655 | -45.2% | 1.7% | -0.8 | 147 947 321 | -22.4% | 4.4% | -0.7 | -20.9% |
| MAT | 1 153 815 | -31.7% | 2.1% | -0.7 | 1 264 649 424 | -11.0% | 4.5% | -1.1 | -10.4% |
| MEZYM | |||||||||
| WoW | 202 269 | -2.2% | 19.9% | 0.6 | 31 740 956 | -2.3% | 13.1% | 0.2 | -5.0% |
| MoM | 1 004 480 | -4.4% | 19.6% | 0.9 | 155 827 241 | -0.0% | 13.4% | 0.7 | -9.0% |
| YTD | 1 701 324 | -54.1% | 19.5% | -10.5 | 266 108 449 | -50.1% | 13.2% | -9.1 | -29.4% |
| MAT | 15 344 475 | -28.1% | 23.7% | -5.8 | 2 376 906 244 | -21.0% | 16.7% | -5.3 | -10.4% |
| MIG 400 | |||||||||
| WoW | 100 820 | 0.8% | 2.2% | 0.1 | 11 462 184 | -3.4% | 1.6% | 0 | -5.8% |
| MoM | 492 476 | -23.1% | 2.3% | -0.1 | 62 993 861 | -19.9% | 1.9% | -0.1 | -18.7% |
| YTD | 834 146 | -45.2% | 2.2% | -1 | 103 467 168 | -40.9% | 1.8% | -1 | -20.6% |
| MAT | 7 707 633 | -25.1% | 3.0% | -0.7 | 922 467 141 | -20.7% | 2.3% | -0.8 | -6.8% |
| PROSTAMOL | |||||||||
| WoW | 19 295 | -13.2% | 13.0% | -0.3 | 29 128 045 | -14.0% | 14.8% | -0.4 | -11.3% |
| MoM | 92 218 | -10.3% | 13.8% | 0.4 | 138 248 618 | -3.9% | 15.6% | 1.2 | -12.6% |
| YTD | 163 474 | -51.8% | 13.4% | -9.2 | 246 843 362 | -44.4% | 15.2% | -8.6 | -18.6% |
| MAT | 1 371 015 | -34.9% | 16.6% | -7.6 | 1 967 467 755 | -26.7% | 18.0% | -8.2 | -5.3% |
| RESPERO MYRTOL | |||||||||
| WoW | 22 653 | -9.8% | 6.9% | -0.2 | 13 146 623 | -10.1% | 8.3% | -0.2 | -6.9% |
| MoM | 103 687 | -36.9% | 7.3% | -1 | 58 772 735 | -31.3% | 8.4% | -0.6 | -28.3% |
| YTD | 186 296 | -41.7% | 7.1% | -3.2 | 107 066 456 | -24.1% | 8.4% | -1.6 | -15.9% |
| MAT | 1 168 253 | 13.3% | 7.7% | 1 | 589 486 319 | 25.8% | 8.2% | 1.3 | -1.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 881 010 | -69.1% | 2.8% | -3.2 | 238 939 600 | -56.1% | 3.4% | -2.4 | -33.0% |
| DEXALGIN | 138 589 | -60.1% | 0.4% | -0.4 | 74 553 635 | -45.0% | 1.3% | -0.8 | -20.6% |
| ESPUMISAN (ADULTS) | 406 440 | -53.3% | 38.9% | -21.5 | 261 128 940 | -36.9% | 49.3% | -17.6 | -27.4% |
| ESPUMISAN BABY | 161 171 | -38.6% | 29.5% | -9.4 | 126 007 911 | -17.8% | 46.7% | -6.5 | -19.1% |
| FASTUM | 115 213 | -47.6% | 0.9% | -0.5 | 70 490 937 | -31.5% | 2.4% | -0.7 | -15.8% |
| IODOMARIN | 491 594 | -17.4% | 21.6% | -0.5 | 91 571 730 | -17.3% | 8.5% | -1.3 | -15.4% |
| LIOTON | 118 655 | -45.2% | 1.7% | -0.8 | 147 947 321 | -22.4% | 4.4% | -0.7 | -20.9% |
| MEZYM | 1 701 324 | -54.1% | 19.5% | -10.5 | 266 108 449 | -50.1% | 13.2% | -9.1 | -29.4% |
| MIG 400 | 834 146 | -45.2% | 2.2% | -1 | 103 467 168 | -40.9% | 1.8% | -1 | -20.6% |
| PROSTAMOL | 163 474 | -51.8% | 13.4% | -9.2 | 246 843 362 | -44.4% | 15.2% | -8.6 | -18.6% |
| RESPERO MYRTOL | 186 296 | -41.7% | 7.1% | -3.2 | 107 066 456 | -24.1% | 8.4% | -1.6 | -15.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 7 872 806 | -46.6% | 4.1% | -2.4 | 1 715 033 572 | -34.1% | 4.2% | -1.8 | -15.4% |
| DEXALGIN | 1 377 010 | -28.0% | 0.5% | -0.2 | 625 815 302 | -14.6% | 1.6% | -0.4 | -6.8% |
| ESPUMISAN (ADULTS) | 3 821 024 | -28.0% | 49.8% | -14.8 | 2 056 077 736 | -16.9% | 56.1% | -13.5 | -6.6% |
| ESPUMISAN BABY | 1 324 984 | -19.0% | 35.5% | -5.3 | 878 367 641 | -8.5% | 49.3% | -6 | -7.1% |
| FASTUM | 936 016 | -31.4% | 1.0% | -0.4 | 513 982 294 | -19.1% | 2.4% | -0.7 | -3.1% |
| IODOMARIN | 3 189 876 | -4.1% | 20.4% | -0.8 | 620 823 811 | 0.0% | 8.9% | -0.7 | -0.4% |
| LIOTON | 1 153 815 | -31.7% | 2.1% | -0.7 | 1 264 649 424 | -11.0% | 4.5% | -1.1 | -10.4% |
| MEZYM | 15 344 475 | -28.1% | 23.7% | -5.8 | 2 376 906 244 | -21.0% | 16.7% | -5.3 | -10.4% |
| MIG 400 | 7 707 633 | -25.1% | 3.0% | -0.7 | 922 467 141 | -20.7% | 2.3% | -0.8 | -6.8% |
| PROSTAMOL | 1 371 015 | -34.9% | 16.6% | -7.6 | 1 967 467 755 | -26.7% | 18.0% | -8.2 | -5.3% |
| RESPERO MYRTOL | 1 168 253 | 13.3% | 7.7% | 1 | 589 486 319 | 25.8% | 8.2% | 1.3 | -1.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 101 174 | -5.6% | 2.7% | 0 | 27 203 998 | -6.6% | 3.3% | 0 | -5.4% |
| DEXALGIN | 14 392 | -7.3% | 0.3% | 0 | 7 957 033 | -7.1% | 1.1% | 0 | -5.8% |
| ESPUMISAN (ADULTS) | 47 914 | -9.4% | 38.7% | 1 | 30 161 157 | -9.9% | 48.2% | 1.2 | -11.9% |
| ESPUMISAN BABY | 19 382 | -6.6% | 29.0% | 0.2 | 15 128 302 | -7.0% | 46.0% | -0.1 | -7.4% |
| FASTUM | 12 656 | -8.7% | 0.8% | 0 | 7 691 928 | -8.6% | 2.2% | 0 | -7.8% |
| IODOMARIN | 61 078 | -11.9% | 22.2% | -0.2 | 11 503 000 | -11.6% | 9.0% | 0 | -11.3% |
| LIOTON | 14 458 | -18.9% | 1.7% | -0.2 | 17 861 918 | -21.1% | 4.3% | -0.6 | -10.2% |
| MEZYM | 202 269 | -2.2% | 19.9% | 0.6 | 31 740 956 | -2.3% | 13.1% | 0.2 | -5.0% |
| MIG 400 | 100 820 | 0.8% | 2.2% | 0.1 | 11 462 184 | -3.4% | 1.6% | 0 | -5.8% |
| PROSTAMOL | 19 295 | -13.2% | 13.0% | -0.3 | 29 128 045 | -14.0% | 14.8% | -0.4 | -11.3% |
| RESPERO MYRTOL | 22 653 | -9.8% | 6.9% | -0.2 | 13 146 623 | -10.1% | 8.3% | -0.2 | -6.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 520 912 | -40.9% | 2.8% | -0.3 | 140 500 936 | -33.7% | 3.5% | 0.1 | -34.9% |
| DEXALGIN | 86 116 | -0.8% | 0.4% | 0.1 | 45 595 997 | 7.9% | 1.4% | 0.3 | -18.7% |
| ESPUMISAN (ADULTS) | 227 468 | -5.8% | 39.3% | -1.6 | 147 485 006 | 4.4% | 50.3% | 1.4 | -1.9% |
| ESPUMISAN BABY | 89 583 | -11.4% | 29.6% | -1.8 | 69 808 712 | -2.9% | 46.7% | -0.1 | -5.9% |
| FASTUM | 68 305 | 1.6% | 0.9% | 0.1 | 41 973 451 | 9.7% | 2.6% | 0.4 | -9.0% |
| IODOMARIN | 257 852 | -11.8% | 20.9% | -1 | 47 712 069 | -11.1% | 8.0% | -0.6 | -7.4% |
| LIOTON | 59 882 | -11.1% | 1.6% | 0 | 74 104 261 | -7.1% | 4.1% | -0.1 | -8.3% |
| MEZYM | 1 004 480 | -4.4% | 19.6% | 0.9 | 155 827 241 | -0.0% | 13.4% | 0.7 | -9.0% |
| MIG 400 | 492 476 | -23.1% | 2.3% | -0.1 | 62 993 861 | -19.9% | 1.9% | -0.1 | -18.7% |
| PROSTAMOL | 92 218 | -10.3% | 13.8% | 0.4 | 138 248 618 | -3.9% | 15.6% | 1.2 | -12.6% |
| RESPERO MYRTOL | 103 687 | -36.9% | 7.3% | -1 | 58 772 735 | -31.3% | 8.4% | -0.6 | -28.3% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"
## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"
## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"
## [1] "ESPUMISAN (ADULTS)"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"
## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"
## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"
## [1] "ESPUMISAN BABY"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"
## [1] "FASTUM"
## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"
## [1] "LIOTON"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"
## [1] "MEZYM"
## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS 20000 IU #20"
## [1] "MEZYM FORTE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #80"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"
## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS 10000 ED #20"
## [1] "DEXALGIN"
## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"
## [1] "MIG 400"
## [1] "MIG 400 COATED TABLETS 400 MG #10"
## [1] "MIG 400 COATED TABLETS 400 MG #20"
## [1] "PROSTAMOL"
## [1] "PROSTAMOL UNO CAPS 320 MG #30"
## [1] "PROSTAMOL UNO CAPS 320 MG #60"
## [1] "PROSTAMOL UNO CAPS 320 MG #90"
## [1] "IODOMARIN"
## [1] "IODOMARIN 100 TABS 100 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #50"
## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"
## [1] "RESPERO MYRTOL"
## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"
## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs